Trial Profile
A retrospective, cross-sectional study to evaluate the evolution of facial aesthetic treatment over five or more years
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial wrinkles; Glabellar lines
- Focus Therapeutic Use
- 16 Dec 2015 New trial record